Keith Serzen
CIK 1310399 · View on SEC EDGAR ↗
First SEC filing: Jan. 5, 2005 · Latest: Jan. 5, 2005
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 9, 2007 | RMD | S | 20,000 | $46.20 | $924,000 | 3,000 Direct | -86.96% | Disposed | 887.1% (price as of 2026-08-19) |
| Nov. 17, 2006 | RMD | S | 10,000 | $49.12 | $491,200 | 2,705 Direct | -78.71% | Disposed | 828.4% (price as of 2026-08-19) |
| June 7, 2006 | RMD | S | 25,000 | $44.52 | $1,113,000 | 2,705 Direct | -90.24% | Disposed | 924.3% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Nov. 7, 2007 | RMD | ResMed Common Stock Options | ReMed Common Stock (55,000) | $42.05 | Nov. 6, 2014 | 55,000 | Acquired |
| Aug. 9, 2007 | RMD | ResMed Stock Options | ReMed Common Stock (20,000) | $20.54 | Jan. 14, 2014 | 20,000 | Disposed |
| Nov. 17, 2006 | RMD | ResMed Stock Options | ReMed Common Stock (10,000) | $21.99 | Sept. 30, 2013 | 10,000 | Disposed |
| Nov. 10, 2006 | RMD | ResMed Stock Options | ReMed Common Stock (45,000) | $46.19 | Nov. 9, 2013 | 45,000 | Acquired |
| Sept. 1, 2006 | RMD | ResMed Stock Options | ReMed Common Stock (10,000) | $40.68 | Aug. 31, 2016 | 10,000 | Acquired |
| June 7, 2006 | RMD | ResMed Stock Options | ReMed Common Stock (25,000) | $21.99 | Oct. 1, 2013 | 25,000 | Acquired |
| Feb. 3, 2006 | RMD | ResMed Stock Options | ResMed Common Stock (45,000) | $38.50 | Feb. 2, 2016 | 45,000 | Acquired |
| Jan. 20, 2005 | RMD | ResMed Options | ResMed Common Stock (6,000) | $49.87 | Jan. 19, 2015 | 6,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 4 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Jan. 5, 2005 | RMD | ResMed Common Stock | 424 | Direct |
| Jan. 5, 2005 | RMD | ResMed Options→ ResMed Common Stock (25,000) | 25,000 | Direct |
| Jan. 5, 2005 | RMD | ResMed Options→ ResMed Common Stock (10,000) | 10,000 | Direct |
| Jan. 5, 2005 | RMD | ResMed Options→ ResMed Common Stock (30,000) | 30,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2008 | $348,750 | $0 | — | — | $177,403 | — | $47,315 | $1,085,417 |
| 2006 | $20,062,005 | $293,750,249,999 | — | — | — | — | $82,166,938 | — |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.